PharmTech Talk

Dec 14, 2015
The use of drug compounding facilities to produce over-priced generic drugs raises quality and regulatory questions.
Dec 14, 2015
Pharmaceutical Technology
This month marks the death of a pragmatic, original thinker who helped make PAT and QbD a reality at more pharmaceutical facilities throughout the world.
Nov 26, 2015
Innovation and technology will be important differentiators for pharmaceutical companies trying to drive sustained growth in emerging markets.
Nov 24, 2015
Text from a merger prospectus reveals the termination fee for the proposed Pfizer-Allergan deal would change if any new tax regulations were passed prior to the closing of the transaction.
Nov 23, 2015
By Pharmaceutical Technology Editors
FDA emphasizes the surveillance aspects of quality metrics to concerned drug manufacturers.
Nov 18, 2015
Robert Califf addresses questions about drug pricing at the Senate hearing to weigh his appointment to be the next commissioner of FDA.
Nov 18, 2015
Experts at the ISPE annual meeting describe best practices, including containment and production in classified spaces.
Nov 06, 2015
Even though rising production and use of generic pharmaceuticals is saving billions for the nation’s healthcare system, policy makers continue to slap the industry with policies it claims will limit product development and sales.
Nov 05, 2015
Biotech boom, niche markets, smaller batch sizes and high potency manufacturing are among the key trends shaping the pharmaceutical industry of the 21st century, according to Christian Treitel from Bosch Packaging Technology.
Oct 30, 2015
Everyone talks about “open innovation,” but without the right working culture it won’t succeed. MeetingZone’s Anthony Prior explains how unified communications can help kick-start the necessary change.
native1_300x100
lorem ipsum